Voyager Therapeutics, Inc. announced the appointment of Catherine J. Mackey, Ph.D. to its Board of Directors. Dr. Mackey is a seasoned life science executive with more than thirty years of operational experience highlighted by her tenure as Senior Vice President, Global Research & Development, for Pfizer, Inc. During her tenure at Pfizer, Dr. Mackey led La Jolla Labs where she oversaw more than 1,000 staff on a one-million square foot campus, delivering a steady-state pipeline of more than two dozen development compounds. Prior to her role at Pfizer La Jolla, Dr. Mackey led Strategic Alliances at its R&D headquarters, where she gained extensive experience with both corporate and academic partnerships in the U.S. and global markets.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.15 USD | +4.22% | +0.62% | -3.44% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.44% | 43Cr | |
+52.36% | 5.67TCr | |
-3.86% | 4.1TCr | |
+38.14% | 3.81TCr | |
-12.01% | 2.69TCr | |
+14.13% | 2.56TCr | |
-21.62% | 1.86TCr | |
+0.21% | 1.24TCr | |
+25.96% | 1.2TCr | |
+23.02% | 1.19TCr |
- Stock Market
- Equities
- VYGR Stock
- News Voyager Therapeutics, Inc.
- Voyager Therapeutics Appoints Catherine J. Mackey, Ph.D. to Its Board of Directors